These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11241061)

  • 1. Ophthalmic drops causing coma in an infant.
    Berlin RJ; Lee UT; Samples JR; Rich LF; Tang-Liu DD; Sing KA; Steiner RD
    J Pediatr; 2001 Mar; 138(3):441-3. PubMed ID: 11241061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of brimonidine ophthalmic drops ingestion in 52 dogs.
    Welch SL; Richardson JA
    Vet Hum Toxicol; 2002 Feb; 44(1):34-5. PubMed ID: 11824775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric systemic poisoning resulting from brimonidine ophthalmic drops.
    Fernandez MA; Rojas MD
    Pediatr Emerg Care; 2009 Jan; 25(1):59. PubMed ID: 19148021
    [No Abstract]   [Full Text] [Related]  

  • 4. Is brimonidine ophthalmic a safe therapy for infants?
    Daubert GP
    J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can ophthalmic drops cause central nervous system depression and cardiogenic shock in infants?
    Kiryazov K; Stefova M; Iotova V
    Pediatr Emerg Care; 2013 Nov; 29(11):1207-9. PubMed ID: 24196091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unintentional ingestion of brimonidine antiglaucoma drops: a case report and review of the literature.
    Soto-Pérez-de-Celis E; Skvirsky DO; Cisneros BG
    Pediatr Emerg Care; 2007 Sep; 23(9):657-8. PubMed ID: 17876259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of 0.2% brimonidine in patients with open-angle glaucoma or ocular hypertension].
    Shi JM; Jiang YQ
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):263-6. PubMed ID: 12575311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Bowman RJ; Cope J; Nischal KK
    Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenoceptor agonist poisoning after accidental oral ingestion of brimonidine eye drops.
    Hoffmann U; Kuno S; Franke G; Fusch C; Haas JP
    Pediatr Crit Care Med; 2004 May; 5(3):282-5. PubMed ID: 15115569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brimonidine tartrate poisoning in children: frequency, trends, and use of naloxone as an antidote.
    Lai Becker M; Huntington N; Woolf AD
    Pediatrics; 2009 Feb; 123(2):e305-11. PubMed ID: 19124581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central alpha-2 adrenergic eye drops: case series of 3 pediatric systemic poisonings.
    Rangan C; Everson G; Cantrell FL
    Pediatr Emerg Care; 2008 Mar; 24(3):167-9. PubMed ID: 18347496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size.
    Kesler A; Shemesh G; Rothkoff L; Lazar M
    J Cataract Refract Surg; 2004 Aug; 30(8):1707-10. PubMed ID: 15313294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.
    Edwards JD; Burka JM; Bower KS; Stutzman RD; Sediq DA; Rabin JC
    J Cataract Refract Surg; 2008 Sep; 34(9):1538-41. PubMed ID: 18721716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic side effects of ophthalmic drops.
    Levy Y; Zadok D
    Clin Pediatr (Phila); 2004; 43(1):99-101. PubMed ID: 14968900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe systemic toxicity caused by brimonidine drops in an infant with presumed juvenile xanthogranuloma.
    Walters G; Taylor RH
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():797-8. PubMed ID: 10707152
    [No Abstract]   [Full Text] [Related]  

  • 16. Brimonidine versus dapiprazole: Influence on pupil size at various illumination levels.
    Marx-Gross S; Krummenauer F; Dick HB; Pfeiffer N
    J Cataract Refract Surg; 2005 Jul; 31(7):1372-6. PubMed ID: 16105609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorespiratory depression and hyperglycemia after unintentional ingestion of brimonidine in a neonate.
    Vanhaesebrouck S; Cossey V; Cosaert K; Allegaert K; Naulaers G
    Eur J Ophthalmol; 2009; 19(4):694-5. PubMed ID: 19551691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes.
    Thordsen JE; Bower KS; Warren BB; Stutzman R
    J Cataract Refract Surg; 2004 Aug; 30(8):1702-6. PubMed ID: 15313293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
    Yuen NS; Cheung P; Hui SP
    Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis.
    Lee JH; You YS; Choe CM; Lee ES
    J Cataract Refract Surg; 2008 Jun; 34(6):963-7. PubMed ID: 18499002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.